$26.18
Price
$5.3B
Market Cap
—
P/E Ratio
-8.7
Forward P/E
$-2.82
EPS (TTM)
—
Dividend Yield
$522M
Cash
$98000
Total Debt
201M
Shares Out
$12.72
$27.80
52-Week Range
Institutional Ownership of IMMUNOVANT INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for IMMUNOVANT INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q2 | |||||
| SELL | EXIT | — | — | $15.15 | |
| 2025-Q1 | |||||
| SELL | -20.8% | 1.1M | $19M | $20.41 | |
| 2024-Q4 | |||||
| SELL | -39.4% | 1.4M | $35M | $28.89 | |
| 2024-Q2 | |||||
| BUY | +28.3% | 2.3M | $61M | $28.61 | |
| 2024-Q1 | |||||
| BUY | NEW | 1.8M | $58M | $36.61 | |
Insider Trading for IMMUNOVANT INC
6 Months Insider Sentiment
Buy $350.0M
Sell $1.6M
1
Buys
14
Sells
+348.4M
Net
0
Grants
Largest
$350.0M
Ltd.
$448K
Fromkin
$303K
Hughes
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 07, 2026 | Jay S Stout | Chief Technology Officer | SELL | 55 | $26.92 | $1K |
| Jan 07, 2026 | Jay S Stout | Chief Technology Officer | SELL | 1.1K | $26.51 | $30K |
| Dec 18, 2025 | Tuyl Christopher Van | Chief Legal Officer | SELL | 8.5K | $26.78 | $228K |
| Dec 18, 2025 | Tuyl Christopher Van | Chief Legal Officer | SELL | 2.3K | $27.38 | $63K |
| Dec 12, 2025 | Roivant Sciences Ltd. | Director, 10% Owner | BUY | 16.67M | $21.00 | $350.0M |
| Dec 01, 2025 | Andrew J. Fromkin | Director | SELL | 2.9K | $23.95 | $69K |
| Dec 01, 2025 | Douglas J. Hughes | Director | SELL | 1.9K | $23.96 | $46K |
| Dec 01, 2025 | Andrew J. Fromkin | Director | SELL | 19.4K | $23.14 | $448K |
| Dec 01, 2025 | Douglas J. Hughes | Director | SELL | 13.1K | $23.14 | $303K |
| Nov 20, 2025 | Melanie Gloria | Chief Operating Officer | SELL | 10.3K | $23.54 | $241K |
| Nov 20, 2025 | Melanie Gloria | Chief Operating Officer | SELL | 2.4K | $23.97 | $57K |
| Oct 22, 2025 | Michael Geffner | Chief Medical Officer | SELL | 2.6K | $19.03 | $49K |
| Oct 22, 2025 | Jay S Stout | Chief Technology Officer | SELL | 2.5K | $19.03 | $48K |
| Oct 08, 2025 | Michael Geffner | Chief Medical Officer | SELL | 1.3K | $16.30 | $21K |
| Oct 08, 2025 | Jay S Stout | Chief Technology Officer | SELL | 1.6K | $16.30 | $26K |